Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial
Glofitamab 联合 Polatuzumab Vedotin 治疗复发/难治性大 B 细胞淋巴瘤(包括高级别 B 细胞淋巴瘤)的疗效和安全性:一项 Ib/II 期试验的结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00992
Hutchings, Martin; Sureda, Anna; Bosch, Francesc; Larsen, Thomas Stauffer; Corradini, Paolo; Avigdor, Abraham; Terol, María José; Dominguez, Antonio Rueda; Pinto, Antonio; Skarbnik, Alan; Cordoba, Raul; Jørgensen, Judit Meszaros; Zinzani, Pier Luigi; Leung, Wilfred; Bottos, Alessia; Li, Donghang; Relf, James; Tandon, Maneesh; Sellam, Gila; Gritti, Giuseppe